Abstract
In the past several decades, various advances in medical sciences have improved the care of HIV-infected individuals globally. With the advent of antiretroviral therapy (ARV), the incidence of neurological opportunistic infections has been greatly reduced. However, the nonopportunistic condition like neurocognitive impairment is still prevalent among HIV-infected individuals. The studies from India conducted in late 1990s on neurological aspects of HIV have mostly concentrated on dementia or AIDS dementia complex. Over time, the neurocognitive consequences of HIV have gained the attention of Indian clinicians as they impair the quality of life, every day activities, employment, and adherence to the treatment. Despite the fact that the recent gains have increased the focus on the assessment of neurocognitive disorders associated with HIV, the data in India are meager. An attempt has been made in this chapter to analyze and present various central nervous system diseases associated with HIV-1 infection, prevalent in India, grounded on various hospital-based reports covering the country.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Solomon S, Chakraborty A, Yepthomi RD, Detels R (2004) A review of the HIV epidemic in India. AIDS Educ Prev 16(Suppl A):155–169
Gray F, Gherardi R, Scaravilli F (1988) The neuropathology of the acquired immune deficiency syndrome (AIDS). A review. Brain J Neurol 111(Pt 2):245–266
Patrick MK, Johnston JB, Power C (2002) Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility. J Virol 76(16):7923–7931
Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83(18):7089–7093
Kaul M, Lipton SA (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4(3):307–318
Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC et al (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65(1):65–70
Kongsiriwattanakul S, Suankratay C (2011) Central nervous system infections in HIV-infected patients hospitalized at King Chulalongkorn Memorial Hospital. J Med Assoc Thai Chotmaihet Thangphaet 94(5):551–558
Bhigjee AI (2005) Neurological manifestations of HIV infection in Kwazulu-Natal South Africa. J Neurovirol 11(Suppl 1):17–21
Asselman V, Thienemann F, Pepper DJ, Boulle A, Wilkinson RJ, Meintjes G et al (2010) Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS Lond Engl 24(18):2871–2876
Nakasujja N, Musisi S, Robertson K, Wong M, Sacktor N, Ronald A (2005) Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. J Neurovirol 11(Suppl 3):26–29
McArthur JC (2004) HIV dementia: an evolving disease. J Neuroimmunol 157(1–2):3–10
Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2):115–121
Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN et al (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56(2):257–260
Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E et al (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68(5):350–355
d’Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J (2004) Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 55(3):320–328
Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17(10):1539–1545
Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 20(4):146–155
May S, Letendre S, Haubrich R, McCutchan JA, Heaton R, Capparelli E, Ellis R (2007) Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. J Neuroimmune Pharmacol 2(1):97–104
Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD (2004) Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36(1):562–566
Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67(2):311–314
Lanjewar DN, Jain PP, Shetty CR (1998) Profile of central nervous system pathology in patients with AIDS: an autopsy study from India. AIDS Lond Engl 12(3):309–313
Patil VC, Patil HV (2014) Neurological manifestations of HIV-AIDS at a tertiary care center in western Maharashtra. Int J Med Public Health 4:210–217
Dubé MP, Holtom PD, Larsen RA (1992) Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93(5):520–524
Baradkar V, Mathur M, De A, Kumar S, Rathi M (2009) Prevalence and clinical presentation of Cryptococcal meningitis among HIV seropositive patients. Indian J Sex Transm Dis 30(1):19–22
Jaiswal SPB, Hemwani N, Sharma N, Athale S, Chitnis DS (2002) Prevalence of fungal meningitis among HIV positive & negative subjects in Indore (MP state). Indian J Med Sci 56(7):325–329
Sinha S, Satishchandra P, Nalini A, Ravi V, Subbakrishna DK, Jayakumar PN, Chandramukhi A, Shankar SK (2005) New-onset seizures among HIV infected drug naïve patients from south India. Neurol Asia 10:29–33
Garg RK (1999) HIV infection and seizures. Postgrad Med J 75(885):387–390
Satishchandra P, Sinha S (2008) Seizures in HIV-seropositive individuals: NIMHANS experience and review. Epilepsia 49(Suppl 6):33–41
Brew BJ (2001) HIV neurology. Oxford University Press, Oxford, NY
Riedel D, Ghate M, Nene M, Paranjape R, Mehendale S, Bollinger R et al (2006) Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. J Neurovirol 12(1):34–38
Saini S, Barar KV (2014) Assessment of neurocognitive functions in HIV/AIDS patients on HAART using the international HIV dementia scale. Int J Nutr Pharmacol Neurol Dis 4(4):252
Clifford DB (1999) Focal Brain Lesions in People with HIV. Curr Treat Options Neurol 1(2):167–172
Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J et al (2008) Harrison’s principles of internal medicine, 17th edn. McGraw-Hill, New York, p 2961
Anuradha B, Preethi C (2014) Seroprevalence of Toxoplasma IgG antibodies in HIV positive patients in and around Khammam, Telangana State. J Clin Diagn Res JCDR 8(9):DL01–DL02
Sucilathangam G, Palaniappan N, Sreekumar C, Anna T (2013) Serological survey of toxoplasmosis in a district in Tamil Nadu: hospital-based study. Indian J Med Res 137(3):560–563
Meisheri YV, Mehta S, Patel UA (1997) prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med 43(4):93–97
Ashok Kumar EA, Jijiya Bai P (2016) A clinical study of CNS Tuberculomas. IAIM 3(6):101–106
Sarkar C, Sharma MC, Deb P, Singh R, Santosh V, Shankar SK (2005) Primary central nervous system lymphoma--a hospital based study of incidence and clinicopathological features from India (1980-2003). J Neurooncol 71(2):199–204
Powari M, Radotra B, Das A, Banerjee AK (2002) A study of primary central nervous system lymphoma in northern India. Surg Neurol 57(2):113–116
Arvind G, Evangelyne S, Limanukshi A, Devi SB, Singh WJ (2013) Human immunodeficiency virus-associated stroke: an aetiopathogenesis study. J Assoc Physicians India 61(11):793–797
Dobbs MR, Berger JR (2009) Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther 7(10):1263–1271
Factor SA, Troche-Panetto M, Weaver SA (2003) Dystonia in AIDS: report of four cases. Mov Disord Off J Mov Disord Soc 18(12):1492–1498
Satishchandra P (2010) Thomas Mathew. Neurological manifestations associated with HIV infection: Indian perspective. J Assoc Physicians India 14(8):760–765
Babu PG, Gnanamuthu C, Saraswathi NK, Nerurkar VR, Yanagihara R, John TJ (1993) HTLV-I-associated myelopathy in south India. AIDS Res Hum Retroviruses 9(6):499–500
Babu PG, Ishida T, Nesadoss J, John TJ (1995) Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India. Scand J Infect Dis 27(2):105–108
Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD (2000) The clinical, radiological and pathological profile of tuberculous meningitis in 2000 patients with and without human immunodeficiency virus infection. J Neurol Sci 181:118–126
Anita M, Sanjib S, Netravathi M, Satishchandra P, Shankar SK (2015) Subacute and chronic viral infections of nervous system and prion diseases. In: Wadia NH, Khadilkar SV (eds) Neurological practice, vol 2. Elsevier, New Delhi, pp 57–115
Shankar SK, Satishchandra P, Mahadevan A, Yasha TC, Nagaraja D, Taly AB, Prabhakar S, Nath A (2003) Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation? J Neurovirol 1:59–67
Vijay DT, Talasila SR, Lakshmi V (2005) Neurologic manifestations of HIV infection: an Indian hospital-based study. AIDS Read 15:139–145
Sonkar SK, Gupta A, Atam V, Chaudhary SC, Tripathi AK, Sonkar GK (2012) Clinical profile of neurological manifestation in Human Immunodeficiency Virus-positive patients. N Am J Med Sci 4:596–599
Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001) Neurological manifestations of HIV disease. J Assoc Physicians India 49:343–348
Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, Desai A, Chandramuki A, Jayakumar PN, Shankar SK (2000) Profile of neurological disorders associated with HIV/AIDS from Bangalore, South India (1989-1996). Indian J Med Res 111:14–23
Deshpande AK, Patnaik MM (2005) Nonopportunistic neurologic manifestations of the human immunodeficiency virus: an Indian study. Med Gen Med 7(4):2
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Sundarrajan, S., Lulu, S., Arumugam, M. (2017). HIV-1 Related Central Nervous System Diseases: Pathogenesis, Diagnosis, and Treatment – An Indian Scenario. In: Shapshak, P., et al. Global Virology II - HIV and NeuroAIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7290-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7290-6_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7288-3
Online ISBN: 978-1-4939-7290-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)